Talaria Global Equity Fund

Our investment strategy seeks to increase the certainty of global equity returns for investors.

We deliver this through our:

  • Unique and structurally lower-risk investment approach that combines capital growth
    and income generation to deliver a more consistent return profile (smoothing).
  • Portfolio of up to 45 large, globally listed companies.
  • Internationally experienced and personally invested leadership team.

We believe the most compelling way to compound clients’ wealth is by utilising multiple return sources to deliver superior risk-adjusted investment outcomes

Research
Risk
Management
Income & distributions
Compounding
Wealth
  • Long-term compounding of investor wealth
  • Multiple sources of return
  • Quarterly distributions
  • Risk focused investment mindset

The investment process behind the Talaria Global Equity Fund takes a high conviction, value biased approach to construct a portfolio of high quality, large cap companies from around the globe. Our unique investment methodology harnesses the benefits of consistent income generation and capital appreciation to grow investors’ real wealth.

Performance

As at

31/1/2020

1

< Scroll >

1
Month

3
Months

6
Months

1
Year

3 Years (pa)

5 Years (pa)

7 years (pa)

10 Years (pa)

Since Inception (pa)2

Income %

0.00

1.30

2.70

8.84

8.44

8.41

9.77

7.46

7.26

Growth %

3.56

4.89

7.90

10.39

2.68

-0.14

2.31

2.36

0.01

Total Return %

3.56

6.19

10.60

19.24

11.13

8.28

12.08

9.28

7.27

Avg. Market Exposure 5

58%

58%

57%

57%

60%

61%

60%

62%

62%

1 Fund Returns are calculated after fees and expenses and assume the reinvestment of distributions.
2 Inception date for performance calculation is 18 August 2008.
3 Income includes realised capital gains.
4 Past performance is not a reliable indicator of future performance.
5 Average Market Exposure calculated on delta-adjusted exposure of underlying portfolio. Since inception market exposure is calculated from September 2008.

Growth of $10,000 since inception 6

Annual Distributions 7

6 Calculations are based on exit price, net of management fees and expenses and assumes reinvestment of distributions Past performance is not a reliable indicator of future performance.
7 Illustrates Distribution Returns for the Talaria Global Equity Fund - Wholesale Units for the financial year ending 30 June 2019. Inception date is 18 August 2008.

Top 10 holdings 8

WPP

Holdings %

5.4

Country

United Kingdom

Sector

Media

Description

World leader in advertising and marketing services

Sanofi

Holdings %

5.1

Country

France

Sector

Health Care

Description

Top 5 pharmaceutical firm with leading positions in diabetes and rare diseases

Johnson & Johnson

Holdings %

4.6

Country

USA

Sector

Health Care

Description

Pharmaceutical, medical devices and consumer health products company

Roche

Holdings %

4.4

Country

Switzerland

Sector

Health Care

Description

A global leader in Cancer treatments

Bayer

Holdings %

4.2

Country

Germany

Sector

Pharmaceuticals

Description

Multinational pharmaceutical and life sciences company

Centrica

Holdings %

3.9

Country

United Kingdom

Sector

Utilities

Description

UK based electricity and gas supplier

Land Securities

Holdings %

3.8

Country

United Kingdom

Sector

Real Estate

Description

Largest commercial property development and investment company in UK

McKesson

Holdings %

3.7

Country

USA

Sector

Health Care

Description

Largest pharmaceutical distributor in North America

Publicis

Holdings %

3.4

Country

France

Sector

Communication Services

Description

One of the oldest and largest marketing and communication companies in the world

Wheaton Precious Metals

Holdings %

3.3

Country

USA

Sector

Materials

Description

Large precious metals streaming company

Company Name

Holding %

Country

Sector

Description

WPP

5.4

United Kingdom

Media

World leader in advertising and marketing services

Sanofi

5.1

France

Health Care

Top 5 pharmaceutical firm with leading positions in diabetes and rare diseases

Johnson & Johnson

4.6

USA

Health Care

Pharmaceutical, medical devices and consumer health products company

Roche

4.4

Switzerland

Health Care

A global leader in Cancer treatments

Bayer

4.2

Germany

Pharmaceuticals

Multinational pharmaceutical and life sciences company

Centrica

3.9

United Kingdom

Utilities

UK based electricity and gas supplier

Land Securities

3.8

United Kingdom

Real Estate

Largest commercial property development and investment company in UK

McKesson

3.7

USA

Health Care

Largest pharmaceutical distributor in North America

Publicis

3.4

France

Communication Services

One of the oldest and largest marketing and communication companies in the world

Wheaton Precious Metals

3.3

USA

Materials

Large precious metals streaming company

8 Weightings include option positions held and cash backing put options. It assumes that put options will be exercised. Should the put option not be exercised the cash will revert to the unencumbered cash portfolio or may be used to cover further put options.

Sector Allocation 9

Regional Allocation 10

9,10 Weightings include option positions held and cash backing put options It assumes that put options will be exercised. Should the put option not be exercised the cash will revert to the unencumbered cash portfolio or may be used to cover further put options.

Fund Snapshot

APIR Code
AUS0035AU
Inception Date
18 August 2008
Management Fee
1.16% p.a.
Liquidity
Daily
Buy / Sell Spread
0.20% / 0.20%
Distributions
Quarterly
Recoverable Expenses
0.12% of the net asset value of the Fund for the financial year
Major Platform Availability
AMP North, Asgard, Ausmaq, BT Wrap, BT Panorama, CFS FirstWrap, Hub24, IOOF Pursuit, Linear, Macquarie, MyNorth, Netwealth, Powerwrap, Praemium, Xplore Wealth

Reports and Disclosure Documents

Important Notice

Wholesale Units in the Talaria Global Equity Fund (the Fund) are issued by Australian Unity Funds Management Limited ABN 60 071 497 115, AFS Licence No. 234454.Talaria Asset Management Pty Ltd ABN 67 130 534 342, AFS Licence No, 333732 is the investment manager and distributor of the Fund. References to “we” meansTalaria Asset Management Pty Ltd, the investment manager. The information in this document is general information only and is not based on the objectives, financial situation or needs of any particular investor. In deciding whether to acquire, hold or dispose of the product you should obtain a copy of the current ProductDisclosure Statement (PDS) for the Fund and consider whether the product is appropriate for you. A copy of the PDS is available at australianunity.com.au/wealthor by calling Australian Unity Wealth Investor Services team on 13 29 39. Investment decisions should not be made upon the basis of the Fund’s past performance or distribution rate, or any ratings given by a rating agency, since each of these can vary. In addition, ratings need to be understood in the context of the full report issued by the rating agency itself. The information provided in the document is current at the time of publication.

Wholesale Investor Confirmation

By clicking below you are confirming that you are an Australian wholesale client for the purposes of section 761G of the Corporations Act 2001. Access to this information is provided on the condition that it is not passed on to any person who is a retail client within the meaning of section 761G of the Corporations Act 2001.